Company
Bioxyne Ltd
ASX:BXN
Bioxyne is an international healthcare, life sciences and novel medicines development company with operations in Australia (head office), United Kingdom, Japan, Czechia, Germany, and the United States serving customers world-wide.
15 stories
Bioxyne among leading ASX % Gainers on high volume
Bioxyne has traded $850,000 worth of stock by noon.
Bioxyne gets ready to raise
The halt will remain in place until Wednesday 19th April 2017.
Bioxyne gets ready to market its probiotics in China via JD.com
JD.com is one of the two largest consumer e-tailers in China.